Real-world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non-valvular atrial fibrillation patients in England.
Ameet BakhaiHans PetriFarnaz VahidniaCyrill WolfYingjie DingNadia FoskettMark SculpherPublished in: Journal of evaluation in clinical practice (2020)
These data provide temporal insights into AF treatment patterns and outcomes for NVAF patients in England and highlight the need to review higher stroke risk AF patients not receiving antiplatelet/antithrombotic prescriptions.
Keyphrases
- atrial fibrillation
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- risk factors
- patient reported outcomes
- oral anticoagulants
- machine learning
- weight loss
- left ventricular
- acute coronary syndrome
- brain injury
- left atrial appendage
- artificial intelligence
- aortic valve
- smoking cessation
- patient reported